PrEP Access Challenges in Atlanta
This is a Georgia news story, published by KFF Health News, that relates primarily to Biden news.
Georgia news
For more Georgia news, you can click here:
more Georgia newsBiden news
For more Biden news, you can click here:
more Biden newsdrug discoveries news
For more drug discoveries news, you can click here:
more drug discoveries newsKFF Health News news
For more news from KFF Health News, you can click here:
more news from KFF Health NewsAbout the Otherweb
Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
HIV prevention funding. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest HIV prevention news, HIV treatment news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
HIV Prevention ProgramKFF Health News
•Health
Health
Biden Rule Cleared Hurdles to Lifesaving HIV Drug, but in Georgia Barriers Remain - KFF Health News
84% Informative
Preexposure prophylaxis, known as PrEP , reduces the risk of new HIV infections through sex by 99% .
Among states, Georgia has the highest rate of new infections, but residents often not getting PrEP.
A rule enacted by the Biden administration that took effect for many Affordable Care Act plans on Jan. 1 should make it easier.
The rule will not help the uninsured.
In Georgia , about 1 million adults under age 65 are uninsured.
Expanding Medicaid would help.
The U.S. list price for lenacapavir as an HIV treatment averages about $40,000 a year.
Some who need PrEP have unstable housing without firm mailing addresses.
VR Score
87
Informative language
88
Neutral language
46
Article tone
semi-formal
Language
English
Language complexity
43
Offensive language
likely offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
20
Source diversity
17
Affiliate links
no affiliate links